BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28429253)

  • 21. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
    Hinke SA; Martens GA; Cai Y; Finsi J; Heimberg H; Pipeleers D; Van de Casteele M
    Br J Pharmacol; 2007 Apr; 150(8):1031-43. PubMed ID: 17339833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin-induced anticancer activities: recent insights.
    Safe S; Nair V; Karki K
    Biol Chem; 2018 Mar; 399(4):321-335. PubMed ID: 29272251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIRT3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells.
    Wu Y; Gao WN; Xue YN; Zhang LC; Zhang JJ; Lu SY; Yan XY; Yu HM; Su J; Sun LK
    Exp Cell Res; 2018 Jun; 367(2):137-149. PubMed ID: 29580688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorophyll-Mediated Changes in the Redox Status of Pancreatic Cancer Cells Are Associated with Its Anticancer Effects.
    Vaňková K; Marková I; Jašprová J; Dvořák A; Subhanová I; Zelenka J; Novosádová I; Rasl J; Vomastek T; Sobotka R; Muchová L; Vítek L
    Oxid Med Cell Longev; 2018; 2018():4069167. PubMed ID: 30057678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generator-specific targets of mitochondrial reactive oxygen species.
    Bleier L; Wittig I; Heide H; Steger M; Brandt U; Dröse S
    Free Radic Biol Med; 2015 Jan; 78():1-10. PubMed ID: 25451644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of Mitochondrial Transcription Inhibitors Active in Pancreatic Cancer Cells.
    Chen W; Hu S; Mao S; Xu Y; Guo H; Li H; Paulsen MT; Chen X; Ljungman M; Neamati N
    ChemMedChem; 2020 Nov; 15(21):2029-2039. PubMed ID: 32748543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Itraconazole inhibits proliferation of pancreatic cancer cells through activation of Bak-1.
    Jiang F; Xing HS; Chen WY; Du J; Ruan YL; Lin AY; Zhou CZ
    J Cell Biochem; 2019 Mar; 120(3):4333-4341. PubMed ID: 30260036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells.
    Müller S; Versini A; Sindikubwabo F; Belthier G; Niyomchon S; Pannequin J; Grimaud L; Cañeque T; Rodriguez R
    PLoS One; 2018; 13(11):e0206764. PubMed ID: 30399175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
    Zhou C; Sun H; Zheng C; Gao J; Fu Q; Hu N; Shao X; Zhou Y; Xiong J; Nie K; Zhou H; Shen L; Fang H; Lyu J
    Cell Death Dis; 2018 Feb; 9(2):161. PubMed ID: 29415987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective Induction of Cellular Toxicity and Anti-tumor Efficacy by N-Methylpiperazinyl Diarylidenylpiperidone and its Pro-nitroxide Conjugate through ROS-mediated Mitochondrial Dysfunction and G2/M Cell-cycle Arrest in Human Pancreatic Cancer.
    Mast JM; Hinds JW; Tse D; Axelrod K; Kuppusamy ML; Kmiec MM; Bognár B; Kálai T; Kuppusamy P
    Cell Biochem Biophys; 2020 Jun; 78(2):191-202. PubMed ID: 32449075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of metformin against palmitate-induced hepatic cell death.
    Geng Y; Hernández Villanueva A; Oun A; Buist-Homan M; Blokzijl H; Faber KN; Dolga A; Moshage H
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165621. PubMed ID: 31786336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
    Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
    Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling.
    Brand MD
    Free Radic Biol Med; 2016 Nov; 100():14-31. PubMed ID: 27085844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic drug levofloxacin inhibits proliferation and induces apoptosis of lung cancer cells through inducing mitochondrial dysfunction and oxidative damage.
    Song M; Wu H; Wu S; Ge T; Wang G; Zhou Y; Sheng S; Jiang J
    Biomed Pharmacother; 2016 Dec; 84():1137-1143. PubMed ID: 27780143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondria-targeted paraquat and metformin mediate ROS production to induce multiple pathways of retrograde signaling: A dose-dependent phenomenon.
    Chowdhury AR; Zielonka J; Kalyanaraman B; Hartley RC; Murphy MP; Avadhani NG
    Redox Biol; 2020 Sep; 36():101606. PubMed ID: 32604037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uncoupling protein-2 knockdown mediates the cytotoxic effects of cisplatin.
    Santandreu FM; Roca P; Oliver J
    Free Radic Biol Med; 2010 Aug; 49(4):658-66. PubMed ID: 20595066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway.
    Wandee J; Prawan A; Senggunprai L; Kongpetch S; Kukongviriyapan V
    Life Sci; 2019 Jan; 217():155-163. PubMed ID: 30528773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators.
    Cheng G; Zielonka J; Hardy M; Ouari O; Chitambar CR; Dwinell MB; Kalyanaraman B
    Oncotarget; 2019 May; 10(37):3518-3532. PubMed ID: 31191823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin.
    Gui DY; Sullivan LB; Luengo A; Hosios AM; Bush LN; Gitego N; Davidson SM; Freinkman E; Thomas CJ; Vander Heiden MG
    Cell Metab; 2016 Nov; 24(5):716-727. PubMed ID: 27746050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation.
    Cheng G; Hardy M; You M; Kalyanaraman B
    Sci Rep; 2022 Mar; 12(1):5143. PubMed ID: 35332210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.